The Clorox Company (NYSE:CLX) Shares Sold by Parkside Financial Bank & Trust

Parkside Financial Bank & Trust reduced its stake in shares of The Clorox Company (NYSE:CLX) by 29.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 332 shares of the company’s stock after selling 138 shares during the quarter. Parkside Financial Bank & Trust’s holdings in Clorox were worth $47,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Fortitude Family Office LLC acquired a new position in Clorox during the fourth quarter worth about $29,000. Tyler Stone Wealth Management grew its position in shares of Clorox by 64.5% in the third quarter. Tyler Stone Wealth Management now owns 255 shares of the company’s stock valued at $33,000 after purchasing an additional 100 shares during the last quarter. Hartford Financial Management Inc. grew its position in shares of Clorox by 57.1% in the fourth quarter. Hartford Financial Management Inc. now owns 256 shares of the company’s stock valued at $37,000 after purchasing an additional 93 shares during the last quarter. Valley National Advisers Inc. grew its position in shares of Clorox by 458.3% in the fourth quarter. Valley National Advisers Inc. now owns 268 shares of the company’s stock valued at $38,000 after purchasing an additional 220 shares during the last quarter. Finally, BKM Wealth Management LLC acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $41,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

NYSE:CLX opened at $146.48 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The company has a market cap of $18.18 billion, a P/E ratio of 232.51, a P/E/G ratio of 2.34 and a beta of 0.43. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $178.21. The firm’s 50 day moving average is $149.39 and its two-hundred day moving average is $142.47.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $1.08. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. Clorox’s revenue was up 16.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.98 earnings per share. Analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Stockholders of record on Wednesday, April 24th will be paid a $1.20 dividend. This represents a $4.80 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date is Tuesday, April 23rd. Clorox’s dividend payout ratio is presently 761.92%.

Analysts Set New Price Targets

Several analysts have recently commented on CLX shares. Barclays lowered their price target on shares of Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 10th. Jefferies Financial Group upgraded shares of Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target on the stock in a research report on Tuesday, March 26th. The Goldman Sachs Group started coverage on shares of Clorox in a research report on Friday, March 1st. They issued a “sell” rating and a $140.00 price target on the stock. JPMorgan Chase & Co. increased their price target on shares of Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating on the stock in a research report on Wednesday, April 17th. Four research analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to MarketBeat.com, Clorox has a consensus rating of “Hold” and an average price target of $148.63.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.